Abbott Laboratories Receivables 2010-2024 | ABT

Abbott Laboratories receivables for the quarter ending September 30, 2024 were $6.854B, a 11.05% increase year-over-year.

  • Abbott Laboratories receivables for 2023 were $6.565B, a 5.58% increase from 2022.
  • Abbott Laboratories receivables for 2022 were $6.218B, a 4.15% decline from 2021.
  • Abbott Laboratories receivables for 2021 were $6.487B, a 1.14% increase from 2020.

Abbott Laboratories Receivables 2010-2024 | ABT

  • Abbott Laboratories receivables for 2023 were $6.565B, a 5.58% increase from 2022.
  • Abbott Laboratories receivables for 2022 were $6.218B, a 4.15% decline from 2021.
  • Abbott Laboratories receivables for 2021 were $6.487B, a 1.14% increase from 2020.